When Is Trigeminal Neuralgia Surgery Considered? What Happens When Medicines Stop Working

She had learned to eat on the right side of her mouth, to shower with her back to the spray, to let the wind hit her shoulder rather than her cheek. The third change to her prescription had bought a few quiet weeks, then the shocks came back: lightning down the jaw, thirty times a day, each one a reason to freeze mid-sentence. When her neurologist said the words surgical opinion, her first reaction was not relief. It was fear.

That moment, the pivot from pills to procedures, is where most people first ask when is trigeminal neuralgia surgery considered, and whether it means an operation on the brain. The honest answer is more nuanced than either a hard yes or a hard no.

This explainer walks through what neurologists and neurosurgeons weigh, how each procedure actually works, what recovery tends to look like, and which questions are worth bringing to the consultation.

When is trigeminal neuralgia surgery considered? The short version

Most specialists frame the decision around three doors, any one of which can open the conversation. The first is loss of control: the medicine that once switched off the attacks now leaves breakthrough pain even after the prescriber has adjusted it as far as is reasonable. The second is side effects: drowsiness, dizziness, unsteadiness or a low blood sodium level that make daily life harder than the pain itself. The third is intolerance: an allergic rash, an abnormal blood test or a drug interaction that rules the medicine out entirely.

Guidance from the NHS and Mayo Clinic describes surgery in exactly these terms, as an option when medicines fail to control symptoms or produce unacceptable effects. There is no rule that says a person must fail two drugs, or wait a set number of months. A younger, otherwise healthy adult whose MRI shows a blood vessel pressing on the nerve may be offered a surgical consultation relatively early, because the operation that addresses that contact tends to give the longest relief. An older adult with heart disease may be steered toward a gentler procedure or asked to try a second medicine first.

What matters is that the referral is a conversation, not a verdict. A surgical opinion does not commit anyone to an operation. It adds a second pair of eyes, a fresh look at the scan and an honest account of what each option can and cannot do. Many people leave that appointment choosing to continue medicine with a clearer plan for the future.

The rest of this article unpacks each of those doors, and what lies behind them.

What trigeminal neuralgia is, and why medicines usually come first

The trigeminal nerve is the fifth of twelve cranial nerves, and it carries sensation from the face to the brain through three branches: forehead and eye, cheek and upper jaw, lower jaw. Neuralgia simply means pain arising from a nerve. Put together, trigeminal neuralgia is a disorder in which that nerve fires off sudden, stabbing, electric-shock pain, usually on one side of the face. According to Mayo Clinic, individual attacks last from a few seconds to about two minutes, and are often set off by light touch, chewing, brushing teeth, speaking or a breeze on the skin.

The most common cause is mechanical. Near the brainstem, the nerve loses some of its insulating coating, called myelin, and a small artery or vein pulsing against that vulnerable stretch can make the fibers misfire. Less often the culprit is multiple sclerosis, which damages myelin directly, or, rarely, a growth pressing on the nerve. The condition becomes more common after 50 and affects women more often than men, as the NIH’s National Institute of Neurological Disorders and Stroke notes.

Medicines come first for two reasons. Ordinary painkillers do very little, because the problem is electrical rather than inflammatory; anticonvulsant drugs such as carbamazepine and oxcarbazepine work by damping the sodium channels that let nerve fibers fire, which is why they also treat epilepsy. The NHS describes carbamazepine as the usual first choice. A prompt response to it also helps confirm the diagnosis, since few other facial pains respond so clearly. The second reason is risk. Every procedure carries the possibility of numbness, hearing change or worse, so clinicians reserve them for when tablets have had a fair trial.

Trigeminal neuralgia when medication stops working: what that really means

Refractory is the word clinicians use when pain is no longer adequately controlled despite appropriate treatment, and it rarely arrives as a single event. More often it creeps in. A person notices they need each adjustment sooner than the last. Attacks start slipping through in the late afternoon. The number of daily triggers grows until the safe list is shorter than the dangerous one.

Side effects have their own trajectory. The anticonvulsants used for this condition can cause drowsiness, dizziness, poor balance, double vision, nausea and, in some people, a fall in blood sodium that shows up on routine tests. Rarely they trigger serious skin or blood reactions, which is why prescribers monitor blood counts and liver tests. Second-line options, including the muscle relaxant baclofen and other anticonvulsants such as lamotrigine or gabapentin, may be added or substituted, each with its own profile.

There is also a quieter kind of failure that does not show on any chart. Someone may technically be controlled yet has stopped eating solid food, skips social meals, avoids shaving or kissing a grandchild. Weight loss, dehydration and isolation are legitimate reasons to revisit the plan, and it is worth saying so plainly at appointments.

Two cautions belong here. First, deciding whether a medicine has failed is the prescribing clinician’s call, made with the patient; never stop or reduce an anticonvulsant on your own, since abrupt withdrawal can cause its own problems. Second, a surgical referral does not mean the medicine is dropped. Most people stay on their prescription right up to the procedure and are weaned afterward, on a schedule the team sets.

How trigeminal neuralgia surgery actually works, in plain language

Every procedure for this condition follows one of two philosophies: move the thing pressing on the nerve, or deliberately dull the nerve so it stops transmitting the shocks. The first approach is a single operation. The second comes in several forms.

Microvascular decompression, usually shortened to MVD, is the move-the-vessel operation. Under general anesthesia the surgeon makes a small opening in the skull behind the ear, a procedure called a craniotomy, and uses an operating microscope to find where an artery or vein contacts the nerve near the brainstem. The vessel is gently lifted away and a soft synthetic pad is placed between vessel and nerve so the pulsing no longer reaches it. The nerve itself is left intact, which is why facial sensation is usually preserved.

Percutaneous procedures take the other route. Percutaneous means through the skin: with the person sedated or briefly anesthetized, a fine needle is passed through the cheek, guided by X-ray, to the trigeminal ganglion, the cluster of nerve cells at the base of the skull where the three branches meet. The surgeon then partially injures the pain fibers in one of three ways: heat from a radiofrequency probe, an injection of glycerol, or a small balloon inflated for a minute or two to compress the fibers. Cleveland Clinic and Mayo Clinic describe all three; each trades some facial numbness for relief.

Stereotactic radiosurgery is not surgery in the cutting sense. Dozens of narrow radiation beams converge on the nerve root, damaging it slowly. There is no incision, but the effect builds over weeks rather than hours, as Mayo Clinic notes, so people typically stay on medicine while it takes hold.

MVD, rhizotomy or radiosurgery: how the options compare

Rhizotomy is the umbrella term for the percutaneous procedures above; it means intentionally interrupting nerve fibers. Seeing the options side by side helps explain why one person is offered a craniotomy and another a needle through the cheek. The rows below summarize what mainstream sources such as the NHS, Mayo Clinic and Johns Hopkins describe; specific numbers vary between centers and should come from your own surgeon.

Procedure	What it does	Setting and anesthesia	Typical stay	Main trade-offs
Microvascular decompression (MVD)	Moves the offending blood vessel and pads it away from the nerve; nerve left intact	Operating room, general anesthesia, opening behind the ear	A few days in hospital	Longest-lasting relief on average; carries the risks of brain surgery, including hearing loss on that side
Radiofrequency, glycerol or balloon rhizotomy	Partially injures pain fibers at the ganglion through a needle in the cheek	Procedure suite, sedation or brief anesthesia	Often same day or overnight	Quick effect, repeatable, suits frail or older adults; facial numbness expected; pain returns more often
Stereotactic radiosurgery	Focused radiation damages the nerve root over time	Outpatient, no incision, head frame or mask	Home the same day	Lowest immediate risk; relief delayed by weeks; numbness can develop later

Notice the pattern. As invasiveness falls, so does durability, and the price of gentleness is usually either numbness or a wait. That is the trade every candidate is really weighing, and there is no single right answer to it. A retired teacher who wants one operation and years of quiet may reason differently from an eighty-year-old with a pacemaker who wants relief this week and can accept a numb cheek.

Who is usually offered surgery, and when is trigeminal neuralgia surgery considered too soon?

The strongest candidates for MVD share a recognizable profile: classic shock-like attacks with pain-free intervals, an MRI that shows a vessel touching the nerve, general fitness for several hours of anesthesia, and a preference for the option most likely to last. Younger and middle-aged adults often fall into this group, and Johns Hopkins describes MVD as the approach most likely to preserve sensation.

Percutaneous procedures and radiosurgery are usually discussed with people for whom a craniotomy carries more risk than reward: those in their late seventies and beyond, those with significant heart or lung disease, or those who simply do not want an open operation. They are also the usual choice when trigeminal neuralgia stems from multiple sclerosis, because there is often no vessel to move; Mayo Clinic notes that MVD is generally less suitable in that setting.

Who is asked to wait? First, anyone who has not yet had an adequate medicine trial; a surgical clinic will often send someone back for a second anticonvulsant before proceeding. Second, people whose pain is constant, burning or aching rather than stabbing. This pattern, sometimes called type 2 or atypical trigeminal neuralgia, responds less predictably to every procedure, and surgeons tend to be more cautious about promising anything. Third, people whose diagnosis is not secure. Dental infections, jaw-joint disorders, cluster headache and post-herpetic pain can all masquerade as trigeminal neuralgia, and an operation on the wrong problem helps no one.

Finally, the condition has natural remissions that can last months. A person who is currently pain-free on a modest prescription will often be advised to hold course and revisit if the attacks return.

How serious is trigeminal neuralgia surgery? Microvascular decompression risks and others

MVD is brain surgery, and it is fair to name it as such. The opening is small and the surgeon never enters brain tissue itself, but the work happens millimeters from the brainstem and from the nerves that control hearing and facial movement. The NHS lists the recognized complications: hearing loss on the operated side, which can be permanent; facial numbness or weakness; leakage of cerebrospinal fluid, the clear liquid that cushions the brain, which can require a second procedure to seal; infection or meningitis; stroke; and, rarely, death. Most people experience none of these, but every candidate should hear the list from their own surgeon along with that team’s actual figures.

Percutaneous procedures carry a different profile. Numbness is not a complication here; it is the mechanism. The concerns are about how much and where. Loss of sensation on the surface of the eye can allow scratches and infections to go unnoticed, so eye care becomes part of recovery. A small number of people develop anesthesia dolorosa, a distressing state in which the numb area also aches constantly, and which is hard to treat. Balloon compression can temporarily weaken the chewing muscles on that side. Because the nerve is only partially injured, pain also returns more often than after MVD.

Radiosurgery carries the lowest immediate risk of the three. Its drawbacks are delayed: relief that takes weeks to arrive and numbness that may develop months later.

Published complication rates vary widely with the surgeon, the technique and how long patients are followed, which is why this article quotes none. Ask your team for theirs, and ask how many of these procedures they perform each year.

What is the most long-term treatment for trigeminal neuralgia?

On the available evidence, microvascular decompression provides the longest-lasting relief of any option, and Mayo Clinic, Johns Hopkins and the NHS all describe it that way. The logic is mechanical: MVD is the only procedure aimed at the cause rather than the wiring. If a pulsing vessel is irritating a bare stretch of nerve, cushioning it away removes the irritation while leaving the nerve able to heal. Because the nerve is not injured, sensation is usually preserved, and there is no numbness-for-relief trade.

Long-lasting is not the same as permanent. Relief after MVD can fade over years in a minority of people, sometimes because the pad shifts, sometimes because a different vessel comes into contact, sometimes for reasons no one can identify. Percutaneous procedures usually work quickly but wear off sooner, since injured fibers can regrow; the compensation is that they can be repeated. Radiosurgery sits between the two, with slower onset and intermediate durability.

A candid note on the evidence itself. Almost everything known about how these procedures compare comes from observational series, meaning surgeons reporting on their own patients, rather than from randomized trials that assign people to one option or another. Series differ in how they define relief, how long they follow people and how they count those lost to follow-up. Anyone quoting a precise percentage is quoting one center’s experience, not a universal truth. That does not make the broad ranking unreliable; the direction of the findings is consistent across decades. It does mean that the honest answer to the question is: MVD, most durably, for the right candidate, with no guarantee for any individual.

Trigeminal neuralgia surgery recovery time: what the days and weeks after usually look like

Recovery depends entirely on which procedure was done, so it helps to picture each separately.

After MVD, Johns Hopkins describes a hospital stay of a few days. The first night is usually spent under close observation. Headache, neck stiffness, nausea and fatigue are common early on; the incision behind the ear is small but the muscles around it were moved, and they complain. Many people find the shocks are gone when they wake, though some notice a lag of days. The NHS describes recovery as taking several weeks. Desk work often resumes within that window, while heavy lifting, straining and driving wait for the surgeon’s clearance. Balance can feel off for a while, and hearing on that side is checked at follow-up.

After a percutaneous rhizotomy, most people go home the same day or the next morning with a cheek that feels as if a dental injection has not worn off. Eating is done carefully and on the other side at first. If the eye area is numb, the team will explain how to protect the cornea with lubricating drops and daily checks for redness. Bruising at the needle site fades within days.

After radiosurgery, people typically leave the same day with a pinprick mark where a frame was fixed. The change comes slowly; Mayo Clinic notes relief may take weeks to build, so the medicine continues meanwhile.

In every case, tapering the anticonvulsant is a decision the prescribing clinician makes with you, usually in steps and only once pain has settled. Reducing it too early can cause a confusing flare that looks like failure but is not.

What happens if the pain comes back after surgery?

Recurrence is not rare, and it is not a sign that anything was done wrong. Nerves regrow, pads shift, and a condition that produced a misfiring nerve once can do so again. What matters is recognizing the pattern early and knowing the options.

The first task is to distinguish between kinds of pain. A return of the familiar brief shocks, triggered by touch or chewing, suggests the original problem is reasserting itself. A new, constant, aching numbness in the treated area after a rhizotomy is a different thing, closer to nerve-injury pain, and calls for a different approach. Keeping a simple diary of attacks, triggers and duration for a couple of weeks gives the team something concrete to work with.

Often the first response is pharmacological. Someone who came off an anticonvulsant may find that restarting it, under guidance, controls the returning attacks at a lower intensity than before. Where medicine alone is not enough, procedures can be revisited. Percutaneous rhizotomies are designed to be repeatable, and many people have more than one over a lifetime. Radiosurgery can sometimes be repeated, with added caution about cumulative numbness. A second MVD is possible but technically harder because of scarring from the first, so surgeons weigh it carefully; some will instead suggest a percutaneous procedure after a failed decompression.

The decision loops back to the same weighing described earlier, with one difference: the person now knows from experience how they feel about numbness, about hospitals and about waiting. That lived knowledge is valuable, and a good team will ask for it.

Does trigeminal neuralgia require brain surgery?

No. Most people with this condition never have an operation of any kind. Medicines control the pain for many for years, and natural remissions give some people long stretches with nothing at all. Of the procedures that exist, only microvascular decompression involves opening the skull. The percutaneous options reach the nerve through the cheek with a needle, and radiosurgery involves no incision.

The phrase brain surgery also deserves unpacking, because it frightens people more than the anatomy warrants. MVD takes place in the space between the skull and the brainstem, along the path of the nerve. The surgeon works around the brain, not inside it. That does not make the operation trivial, as the risk section above makes clear, but it does explain why so many people recover with their thinking, speech and personality entirely unchanged.

For people with multiple sclerosis, the calculation is different. The nerve damage sits inside the brainstem itself, where no vessel can be moved away, so MVD usually has little to offer and the percutaneous and radiosurgical options carry the conversation.

Other approaches sit at the margins of the evidence. Botulinum toxin injections along the nerve’s branches have been studied in small trials, and peripheral nerve blocks are sometimes used for temporary relief; neither is established as a durable treatment in mainstream guidance, and they are best understood as options some teams discuss rather than as proven alternatives.

The takeaway is that a referral to a neurosurgeon is a referral for a conversation about the full menu, from continuing tablets to the least invasive procedure to the operating room. Brain surgery is one item on it, not the whole list.

What people often get wrong about trigeminal neuralgia surgery

Some misunderstandings surface at nearly every consultation, and clearing them early saves a lot of worry.

Surgery is only for the old and desperate. The opposite is closer to the truth for MVD. Younger, healthier adults with a clear vessel on MRI tolerate the operation best and stand to gain the most years of relief, which is why many surgeons raise it early rather than late.

If the MRI shows nothing, nothing can be done. Scans miss small vessels, and the diagnosis rests on the story, not the picture. Some people with clean MRIs are found to have compression at operation; others are offered rhizotomy or radiosurgery, which do not depend on finding a vessel.

Numbness means the procedure failed. After a rhizotomy, numbness is the intended effect. The procedure worked precisely because sensation was reduced. After MVD, by contrast, new numbness is a side effect worth reporting.

It must be a tooth. Because the pain often centers on the jaw, people frequently see dentists first, and some have healthy teeth removed before the diagnosis is made. Pain that jumps in electric bursts and is triggered by a breeze on the skin is not typical of dental disease.

A pain-free month means it has gone for good. Remissions are part of the natural history, and attacks often return. A quiet spell is a good reason to enjoy life and a poor reason to stop medicine without the prescriber’s say-so.

Any surgeon can do this. Outcomes for MVD in particular track closely with the surgeon’s experience. Asking how often a team performs the procedure is a legitimate, expected question.

Questions to ask your care team

A surgical consultation moves fast, and the most useful questions are the ones written down beforehand. These are the ones neurosurgeons and neurologists say they wish more people asked.

• Does my pattern of pain fit classic trigeminal neuralgia, or is there anything atypical about it that changes what surgery can offer?
• What does my MRI show, and how confident are you that a blood vessel is the cause?
• Which of the three approaches do you recommend for me, and which would you recommend if I were twenty years older or younger?
• What are your own complication rates for this procedure, and how many do you perform in a typical year?
• What does relief look like in your experience: immediate, or building over weeks?
• What happens to my current medicine before, during and after the procedure, and who manages the taper?
• If the pain comes back, what would the next step be?
• What sensation changes should I expect, and how do I protect my eye if that area becomes numb?
• How long should I plan to be away from work, driving and exercise?
• Is this procedure usually covered by my insurance, and who on your team can help with pre-authorization and paperwork?

Two habits make the answers stick. Bring someone who can take notes while you listen, and ask the team to write down the name of the exact procedure being proposed, since the terminology is confusing and the internet is full of look-alikes. It is entirely reasonable to ask for time to think, or for a second opinion, and good teams expect both.

When to call your doctor

Before any procedure, certain changes mean the plan needs revisiting sooner than the next scheduled visit. Contact the prescribing clinician promptly if a new rash, fever, mouth ulcers, unusual bruising or yellowing of the skin appears while on an anticonvulsant, since these can signal a serious reaction. Marked unsteadiness, confusion, double vision or repeated falls also warrant a call. So does pain so severe that eating and drinking have stopped; dehydration develops quickly. Numbness that becomes constant, new facial weakness, hearing change or pain that has spread to both sides of the face all suggest the diagnosis should be looked at again.

After surgery, the red flags are more specific. Seek urgent care for fever with a stiff neck or severe headache, which can indicate meningitis; clear, watery fluid dripping from the nose, the ear or the incision, which can be cerebrospinal fluid; a wound that becomes red, swollen or leaks pus; sudden hearing loss; new weakness of the face or a limb, slurred speech or confusion; and worsening rather than improving headache. After a rhizotomy, a red, painful or gritty eye on the numb side needs same-day assessment, because the cornea may have been scratched without being felt. Calf pain, swelling or sudden breathlessness in the weeks after any operation can signal a blood clot and are an emergency.

One more sign belongs on this list. Living with trigeminal neuralgia can bring despair, and people have described feeling they cannot go on. If those thoughts arrive, tell your team the same day or contact a crisis line; this pain is treatable, and the people caring for you want to know.

Frequently asked questions

How serious is trigeminal neuralgia surgery?

It depends on the procedure. Microvascular decompression is an open operation near the brainstem under general anesthesia, with recognized risks including hearing loss on that side, cerebrospinal fluid leak, infection, stroke and, rarely, death. Percutaneous procedures through the cheek are far less invasive but deliberately cause facial numbness. Radiosurgery carries the lowest immediate risk. Your surgeon should explain their own complication figures rather than general ones.

Is MVD surgery covered by insurance?

Coverage varies with your plan and country, so no article can answer this for you. In many health systems microvascular decompression is a recognized treatment for trigeminal neuralgia that has not responded to medicines, and it is often covered when a neurologist and neurosurgeon document that history. Ask your care team who handles pre-authorization and request written confirmation from your insurer before scheduling.

What is the most long-term treatment for trigeminal neuralgia?

Microvascular decompression is described by Mayo Clinic, Johns Hopkins and the NHS as the option with the longest-lasting relief, because it removes the blood vessel irritating the nerve rather than injuring the nerve itself. Relief is not guaranteed to be permanent, and pain can return years later in some people. Percutaneous procedures work faster but wear off sooner; radiosurgery sits in between.

How long does it take to recover from trigeminal neuralgia surgery?

For microvascular decompression, Johns Hopkins describes a hospital stay of a few days and the NHS describes recovery over several weeks, with headache, neck stiffness and fatigue common early on. After a percutaneous rhizotomy, most people go home the same day or next morning and adjust to facial numbness over days. After radiosurgery there is little to recover from, but relief itself may take weeks to develop.

Trigeminal neuralgia when medication stops working: what are the next steps?

Tell your prescribing clinician rather than adjusting anything yourself. They may change or add a medicine, order or repeat an MRI to look for a vessel touching the nerve, and refer you to a neurosurgeon for a discussion of options. That referral does not commit you to an operation. Most people continue their medicine throughout and are weaned only after a procedure has settled the pain.

Does trigeminal neuralgia require brain surgery?

No. Many people are managed with medicines alone for years, and only one procedure, microvascular decompression, involves opening the skull. The others reach the nerve with a needle through the cheek or with focused radiation and no incision. Even MVD takes place around the brain rather than inside it, which is why thinking and speech are usually unaffected.

What are the main microvascular decompression risks I should ask about?

Ask specifically about hearing loss on the operated side, which can be permanent, facial numbness or weakness, cerebrospinal fluid leak requiring a second procedure, wound infection or meningitis, stroke and death. These are the complications listed by the NHS. Ask your surgeon for their own rates and how many of these operations they perform each year, since experience matters for this procedure.

Can you have trigeminal neuralgia surgery if you have multiple sclerosis?

Yes, but usually not microvascular decompression. In multiple sclerosis the nerve damage sits inside the brainstem, so there is generally no vessel to move, and Mayo Clinic notes MVD is less suitable in that situation. Percutaneous rhizotomy and stereotactic radiosurgery are the procedures most often discussed, alongside continued medicine. The neurology and neurosurgery teams usually plan this together.

Will my face be numb after trigeminal neuralgia surgery?

After a percutaneous rhizotomy, yes: numbness is how the procedure works, and its extent varies. After radiosurgery, numbness can develop months later in some people. After microvascular decompression, sensation is usually preserved because the nerve is not injured, so new numbness afterward is a side effect worth reporting. If the eye area is numb, protecting the cornea becomes part of daily care.

Can trigeminal neuralgia surgery be repeated if the pain returns?

Often. Percutaneous rhizotomies are designed to be repeatable, and radiosurgery can sometimes be repeated with added caution about cumulative numbness. A second microvascular decompression is possible but harder because of scarring, so surgeons may suggest a percutaneous procedure instead. Restarting medicine under guidance is frequently the first step, and a pain diary helps the team distinguish returning shocks from new nerve-injury pain.

References

• NHS: Trigeminal neuralgia: Treatment
• NIH National Institute of Neurological Disorders and Stroke: Trigeminal Neuralgia
• MedlinePlus: Trigeminal neuralgia

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.